Hebert Schou

  • Hebert Schou posted an update 1 week, 1 day ago

    Coronavirus disease 2019 (COVID-19) remains a global public health threat. Hence, more effective and specific antivirals are urgently needed. Here, COVID-19 hyperimmune globulin (COVID-HIG), a passive immunotherapy, is prepared from the plasma of healthy donors vaccinated with BBIBP-CorV (Sinopharm COVID-19 vaccine). COVID-HIG shows high-affinity…[Read more]

  • Hebert Schou posted an update 1 week, 6 days ago

    ‘s permanent immature teeth by fracture following caries or trauma.

    These ex vivo results suggest that the triple antibiotic paste and calcium hydroxide should be used with propylene glycol if a fast diffusion is desired or with water to avoid degrading the collagen and weakening the microhardness of the teeth. Clinical trials are needed of new…[Read more]

  • Hebert Schou posted an update 2 weeks, 1 day ago

    The probability of recurring strokes in patients with atrial fibrillation is high. Within 1.8 years, 6.6% of the patients suffered a new stroke. While effective secondary prevention options exist, low adherence challenges effective medical treatment. The aim of our study was to examine the risk understanding of acute stroke patients and to find…[Read more]

  • Hebert Schou became a registered member 2 weeks, 1 day ago